Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-factor Xa”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Not applicableStudy completedNCT02925247
What this trial is testing

Specific Anti Factor Xa Activity Dosage to Enhance Detection of Nonadherence in Atrial Fibrillation Patients

Who this might be right for
Atrial Fibrillation
Assistance Publique Hopitaux De Marseille 150
Post-approval studies (Phase 4)Study completedNCT01687491
What this trial is testing

Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary Syndrome

Who this might be right for
Acute Coronary SyndromeFactor X
Les Laboratoires des Médicaments Stériles 179
Testing effectiveness (Phase 2)Study completedNCT04640181
What this trial is testing

Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT)

Who this might be right for
Covid19
St. David's HealthCare 150
Post-approval studies (Phase 4)Looking for participantsNCT06402851
What this trial is testing

Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)

Who this might be right for
Atrium; FibrillationChronic Kidney Diseases
Hospital Sirio-Libanes 1,500
Early research (Phase 1)Study completedNCT02687204
What this trial is testing

Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolus
University of Utah 118
Large-scale testing (Phase 3)Study completedNCT04142125
What this trial is testing

Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease

Who this might be right for
Ischemic StrokeIntracranial Atherosclerotic Disease
Population Health Research Institute 101
Not applicableStudy completedNCT01068795
What this trial is testing

Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome

Who this might be right for
Fetal DemiseFetal Growth RestrictionPreeclampsia+2 more
HaEmek Medical Center, Israel 144
Not applicableStudy completedNCT04268940
What this trial is testing

Thrombo-Elastography Guided Management of ECMO

Who this might be right for
Extracorporeal Circulation of Blood; Thrombocytopenia
Damian Ratano 61
Not applicableStudy completedNCT00319176
What this trial is testing

Evaluation of Pre-dose and Post-dose Anti-factor Xa Levels With Enoxaparin Use During Pregnancy

Who this might be right for
Pregnancy
University of California, Irvine 15
Not applicableStudy completedNCT05221879
What this trial is testing

Anti-factor Xa Based Venous Thromboembolism Prophylaxis

Who this might be right for
Dose Adjustment of Enoxaparin in ICU Patients
Meir Medical Center 75
Very early researchStudy completedNCT02704052
What this trial is testing

Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose

Who this might be right for
Deep Venous ThrombosisPulmonary EmbolusVenous Thromboembolism
University of Utah 116
Not applicableStudy completedNCT05256524
What this trial is testing

Is Anti-Factor Xa Associated With Outcome in Patients With Critical COVID-19 on Low-Molecular-Weight Heparin?

Who this might be right for
Covid19ThromboembolismBleeding
Karolinska Institutet 1,520
Not applicableStudy completedNCT00986635
What this trial is testing

Effect of Rivaroxaban on Coagulation Parameters- an ex Vivo Study

Who this might be right for
Differences in Laboratory Coagulation Parameters
Johann Wolfgang Goethe University Hospital 100
Not applicableUnknownNCT06431789
What this trial is testing

Prospective Observational Association Between SLCO1B1 Gene Polymorphism and the Anti-factor Xa Activity of Edoxaban in Patients With Moderate to Severe Renal Insufficiency

Who this might be right for
Gene PolymorphismEdoxabanRenal Insufficiency
Yi Han 220
Post-approval studies (Phase 4)Study completedNCT00351663
What this trial is testing

The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients

Who this might be right for
Venous ThrombosisCritical Illness
Shaare Zedek Medical Center 39
Not applicableLooking for participantsNCT06357403
What this trial is testing

Association of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill Patients

Who this might be right for
ThrombosisPulmonary EmbolismEnoxaparin
Medical University of Vienna 1,300
Testing effectiveness (Phase 2)WithdrawnNCT00541320
What this trial is testing

Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)

Who this might be right for
Venous Thromboembolism
GlaxoSmithKline
Not applicableUnknownNCT04671160
What this trial is testing

Impact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.

Who this might be right for
Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis
Medical University of Gdansk 80
Early research (Phase 1)Study completedNCT01954238
What this trial is testing

Access Safety, Tolerability, Pharmacokinetics(PK) and Pharmacodynamics(PD) of Orally Administered GCC-4401C in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Green Cross Corporation 46
Not applicableStudy completedNCT03143569
What this trial is testing

Ventricular Assist Device Anti-Factor Xa (VAD ANTIX) Monitoring Study: a Prospective Randomized Feasibility Trial

Who this might be right for
Left Sided Heart FailureLeft Ventricular Assist DeviceAnticoagulant Therapy+5 more
Washington University School of Medicine 20
Load More Results